feed,title,long_url,short_url
Benzinga,Regeneron Faces Setback With FDA Rejection Of Blood-Cancer Treatment,https://benzinga.com/markets/equities/24/08/40476728/regeneron-faces-setback-with-fda-rejection-of-blood-cancer-treatment,https://da.gd/UprE
